Skip to content

Clinical trials

Major Depressive Disorder trials in Finland

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Major Depressive Disorder Country / region: Finland Clear all

54 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20041
20051
20065
20075
20082
20092
20104
20114
20123
20131
20143
20151
20162
20171
20182
20191
20202
20213
20221
20232
20242
20254
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed41
Terminated7
Recruiting3
Active, not recruiting2
Not yet recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
H. Lundbeck A/S7
AstraZeneca5
Sanofi4
Eli Lilly and Company3
Janssen Research & Development, LLC3
Finnish Institute for Health and Welfare2
Forest Laboratories2
GlaxoSmithKline2
Intra-Cellular Therapies, Inc.2
Neumora Therapeutics, Inc.2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Major Depressive Disorder54
Depressive Disorder6
Mood Disorders3
Anhedonia1
Anxiety Disorders1
Depressive Disorder, Treatment-Resistant1
Mental Disorders1
Migraine Disorders1
Substance-Related Disorders1

Trials

Showing 76 to 54 of 54. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.